Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
China Shineway Pharmaceutical Group Ltd
C1SCurrent price
1.01 EUR
-0.02 EUR (-1.94%)
Last closed
8.17 HKD
Company
www.shineway.com
ISIN
KYG2110P1000
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
6 151 133 551 HKD
Yield for 12 month
+7.01 %
1Y
3Y
5Y
10Y
15Y
C1S
China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd. Address: No. 168, Shiluan Street, Shijiazhuang, China, 051430
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
104.92 HKDP/E ratio
5.25Dividend Yield
6.93 %Current Year
+4 797 638 619 HKD
Last Year
+4 196 515 973 HKD
Current Quarter
+2 249 669 404 HKD
Last Quarter
+2 547 969 223 HKD
Current Year
+3 605 362 426 HKD
Last Year
+3 121 189 005 HKD
Current Quarter
+1 689 130 622 HKD
Last Quarter
+1 916 231 812 HKD
Key Figures C1S
1 year
3 years
5 years
10 years
EBITDA
1 105 514 273 HKD
Operating Margin TTM
PE Ratio
5.25
Return On Assets TTM
6.29 %
PEG Ratio
–
Return On Equity TTM
15.81 %
Wall Street Target Price
104.92 HKD
Revenue TTM
4 206 041 821 HKD
Book Value
9.72 HKD
Revenue Per Share TTM
Dividend Share
0.54 HKD
Quarterly Revenue Growth YOY
-13.00 %
Dividend Yield
6.93 %
Gross Profit TTM
3 163 465 792 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
IV 2023
Quarterly Earnings Growth YOY
27.60 %
Profit Margin
26.27 %
Dividend Analytics C1S
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
123.00 %Consecutive Years
2 years5Y Average Payout Ratio
62.00 %Dividend History C1S
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
0.58
Ex Dividend Date
10.09.2024
Forward Annual Dividend Yield
7.14 %
Last Split Factor
–
Payout Ratio
36.74 %
Last Split Date
–
Dividend Date
–
Stock Valuation C1S
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
5.25
Forward PE
–
Enterprise Value Revenue
0.030
Price Sales TTM
1.46
Enterprise Value EBITDA
0.095
Price Book MRQ
0.79
Financials C1S
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators C1S
For 52 weeks
6.90 HKD
10.76 HKD
50 Day MA
9.18 HKD
Shares Short Prior Month
–
200 Day MA
8.84 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart